Literature DB >> 20711321

An eight-week, open-label, prospective case series of acamprosate calcium as monotherapy for patients with comorbid anxiety symptoms and alcohol misuse: an evaluation for alcohol sobriety and anxiolysis.

Thomas L Schwartz, Mark Chilton, Alka Aneja.   

Abstract

Entities:  

Year:  2007        PMID: 20711321      PMCID: PMC2921244     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


× No keyword cloud information.
  2 in total

1.  Clinical guidelines for establishing remission in patients with depression and anxiety.

Authors:  J C Ballenger
Journal:  J Clin Psychiatry       Date:  1999       Impact factor: 4.384

Review 2.  Medications for treating alcohol dependence.

Authors:  Steven H Williams
Journal:  Am Fam Physician       Date:  2005-11-01       Impact factor: 3.292

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.